Ephedrine use is risky business

Current Sports Medicine Reports

Volumn 2, Issue 1, 2003, Pages 1-2

  Landry, Gregory L ^a  

^a UNIVERSITY OF WISCONSIN SCHOOL OF MEDICINE AND PUBLIC HEALTH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CAFFEINE; CENTRAL STIMULANT AGENT; EPHEDRINE;

CARDIOVASCULAR DISEASE; CENTRAL NERVOUS SYSTEM DISEASE; CHEMICALLY INDUCED DISORDER; DIET SUPPLEMENTATION; DOPING; DRUG COMBINATION; DRUG INTERACTION; FOOTBALL; HUMAN; METHODOLOGY; REVIEW;

CAFFEINE; CARDIOVASCULAR DISEASES; CENTRAL NERVOUS SYSTEM DISEASES; CENTRAL NERVOUS SYSTEM STIMULANTS; DIETARY SUPPLEMENTS; DOPING IN SPORTS; DRUG COMBINATIONS; DRUG INTERACTIONS; EPHEDRINE; FOOTBALL; HUMANS;

EID: 0042520911     PISSN: 1537890X     EISSN: 15378918     Source Type: Journal    
DOI: 10.1249/00149619-200302000-00001     Document Type: Article

References (2)

1. Bouchard R, Weber AR, Geiger JD: Informed decision-making on sympathomimetic use in sport and health. Clin J Sport Med2002, 12:209-224.
2. Haller CA, Benowitz NL: Adverse cardiovascular and central nervous system events associated with dietary supplements containing ephedra alkaloids.N Engl J Med2000, 343:1833-1838.